The relationship between tumour metastasis and angiogenesis has been demonstrated in a series of clinical studies involving a wide range of histological types of tumours (Weidner et al, 1991; Macchiarini et al, 1992; Gasparini et al, 1993; Bochner et al, 1995) . These studies showed that the probability of metastasis is positively correlated to the vascular density of the primary tumour and led to the suggestion that vascular density might be an independent prognostic indicator in malignant diseases (Weidner, 1993) . The metastatic propensity of a tumour might be influenced by the angiogenic potential of the tumour cells by two independent mechanisms: high vascular density in the primary tumour might enhance the opportunity of the tumour cells to gain access to the blood stream and elevated capacity to induce neovascularization might increase the probability of tumour cells trapped in distant organ capillary beds to give rise to macroscopic tumour growth (Fidler and Ellis, 1994) .
Significant correlations between tumour metastasis and oxygenation or between tumour metastasis and lactate concentration have been demonstrated in clinical studies involving soft tissue sarcoma (Brizel et al, 1996) , cervix carcinoma (Schwickert et al, 1995; Höckel et al, 1996; Sundfør et al, 1998) and carcinoma of the head and neck (Walenta et al, 1997) . High lactate concentration is indicative of extensive anaerobic metabolism and hence poor oxygenation in tumour tissue (Vaupel et al, 1989) . These studies are apparently inconsistent with those showing correlations between tumour metastasis and angiogenesis as primary tumours with low oxygen tensions or high lactate concentrations were found to metastasize more frequently than primary tumours with high oxygen tensions or low lactate concentrations (Schwickert et al, 1995; Brizel et al, 1996; Höckel et al, 1996; Walenta et al, 1997; Sundfør et al, 1998) . However, they are consistent with a study of experimental murine tumours which showed that tumour cells exposed to transient hypoxia in vitro are more metastatic than aerobic control cells when injected intravenously (i.v.) in syngeneic mice (Young et al, 1988) .
Tumour cells exposed to hypoxia in vitro or in vivo show increased expression of several selected genes, including the gene encoding vascular endothelial growth factor (VEGF) (Dachs and Stratford, 1996) . VEGF is a potent angiogenic factor existing in four different isoforms (VEGF 121, 165, 189, 206 ) arising from alternative m-RNA splicing (Zagzag, 1995) . The expression of VEGF is correlated to vascular density in several histological types of human tumours (Guidi et al, 1995; Toi et al, 1995; Takahashi et al, 1995; Mattern et al, 1996) . Xenografted tumours established from cell lines transfected with VEGF show increased vascular density, volumetric growth rate and metastatic frequency relative to wildtype control tumours (Zhang et al, 1995; Claffey et al, 1996; Pötgens et al, 1996) , whereas xenografted tumours initiated from cell lines transfected with antisense-VEGF c-DNA show reduced vascular density and growth (Saleh et al, 1996) . The neovascularization of experimental tumours is inhibited by treatment with monoclonal antibodies against VEGF (Kim et al, 1993; Asano et al, 1995; Melnyk et al, 1996) .
The possibility thus exists that hypoxic tumour cells after dissemination have increased capacity to induce neovascularization in secondary organ sites and hence are more metastatic than their normoxic counterparts, owing to increased VEGF expression induced by the hypoxic microenvironment. The purpose of the work reported here was to test this hypothesis. Cells from two human melanoma lines differing significantly in VEGF synthesis and secretion were exposed to hypoxia in vitro. Metastatic efficiency, i.e. lung colonization efficiency, was assessed in athymic nude mice after i.v. administration of tumour cells. Transplantability and angiogenic potential were also determined in vivo, using intradermal (i.d.) assays in athymic nude mice. Hypoxia-induced VEGF up-regulation was studied in vitro using Western blot analysis and ELISA.
MATERIALS AND METHODS

Mice
Adult (8-10 weeks old) female BALB/c-nu/nu mice were used as host animals to assess tumour cell metastatic efficiency, transplantability and angiogenic potential. The mice were bred at our institute and maintained under specific pathogen-free conditions at constant temperature (24-26°C) and humidity (30-50%). Sterilized food and tap water were given ad libitum.
Cell lines
Two human melanoma cell lines (A-07 and D-12) giving rise to pulmonary metastases in athymic nude mice were included in the study (Rofstad, 1994) . The cell lines were maintained in monolayer culture in RPMI-1640 medium (25 mM HEPES and L-glutamine) supplemented with 13% fetal calf serum, 250 mg l -1 penicillin and 50 mg l -1 streptomycin. The cultures were incubated at 37°C in a humidified atmosphere of 5% carbon dioxide in air and subcultured twice a week by trypsinization (treatment with 0.05% trypsin-0.02% EDTA solution at 37°C for 2 min). The cell lines were verified to be free from Mycoplasma contamination by using the Hoechst fluorescence and the mycotrin methods.
Hypoxia exposure
Monolayer cell cultures growing in glass dishes were exposed to hypoxia for 0-24 h by using the steel-chamber method (Sanna and Rofstad, 1994) . The cultures were incubated at 37°C in a humidified atmosphere of 5% carbon dioxide in air for 24 h before the hypoxia treatment. The culture medium was removed and replaced by fresh medium immediately before the cells were exposed to hypoxia. The medium used during the hypoxia treatment was supplemented with 2.2 g l -1 sodium bicarbonate. The pH of the medium was 7.4 ± 0.1. The glass dishes were kept in air-tight steel chambers during the hypoxia treatment. The medium layer covering the cells was approximately 2 mm in thickness. The steel chambers were flushed with a humidified, highly purified gas mixture consisting of 95% nitrogen and 5% carbon dioxide at a flow rate of 5 l min -1 . Measurements showed that the concentration of oxygen in the medium was less than 10 ppm after 30 min of flushing. Control cultures were flushed with humidified 5% carbon dioxide in air. The cells were reoxygenated by opening the steel-chambers. The cultures were kept in fresh medium in humidified 5% carbon dioxide in air for reoxygenation times of 0-24 h before the cells were detached from the glass dishes by trypsinization and washed in Ca 2+ -and Mg
2+
-free Hanks' balanced salt solution (HBSS). Cell aggregates were not seen in any of the suspensions.
Cell viability assay
The viability of cells from control and hypoxia-treated cultures was assessed by measuring plating efficiency (PE) in vitro (Rofstad, 1992) . Aliquots of 2.0 × 10 2 cells suspended in 1 ml of fresh medium were plated in 25-cm 2 culture flasks. The flasks contained approximately 1.0 × 10 5 lethally irradiated (30 Gy) feeder cells in 4 ml of medium, plated 24 h earlier. The cells were incubated at 37°C in a humidified atmosphere of 5% carbon dioxide in air for 10 days. The medium was removed and replaced by fresh medium on day 7. The cells were fixed in 100% ethanol and stained with methylene blue. Colonies containing more than 50 cells were counted using a stereomicroscope.
Metastasis assay
Metastatic efficiency was assessed by using a lung colonization assay (Rofstad, 1995) . Aliquots of 2.0 × 10 6 -3.0 × 10 6 A-07 cells or 5.0 × 10 5 D-12 cells suspended in 0.2 ml of HBSS were inoculated into the lateral tail vein of mice by using a tuberculin syringe with a 26-gauge needle. The mice were killed and autopsied 5 weeks after the inoculation. The lungs were removed, rinsed in HBSS and fixed in Bouin's solution for 24 h to facilitate the scoring of colonies. The number of surface colonies was recorded using a stereomicroscope. Metastatic efficiency in terms of number of lung colonies per 1.0 × 10 6 viable A-07 cells or per 1.0 × 10 5 viable D-12 cells was determined by correcting the number of colonies for the number of cells per inoculum and the PE measured in vitro, as recommended by Young et al (1988) .
Transplantation assay
Transplantability was assessed using an intradermal transplantation assay (Rofstad, 1995) . A 100-µl Hamilton syringe was used to inoculate aliquots of 10 µl of cell suspension into the flank of mice. The cells were suspended in HBSS, and the number of cells per inoculum was varied within the ranges 2.0 × 10 3 -2.0 × 10 5 (A-07) and 2.0 × 10 2 -5.0 × 10 4 (D-12). The inoculation point lay above the subcutaneous muscle tissue in the deeper part of the dermis. The mice were examined twice weekly for up to 120 days after the inoculation. A transplantation was scored as positive when the tumour diameters reached 10-12 mm, and then the host was killed. All positive transplantations were scored before day 90 after the inoculation. The fraction of positive transplantations was plotted vs the number of cells per inoculum, and probit regression lines were fitted to the data.
Angiogenesis assay
Angiogenic potential was assessed using an i.d. angiogenesis assay (Kreisle and Ershler, 1988) . Aliquots of 10 µl of cell suspension were inoculated i.d. in mice, using the same procedure as used in the transplantability studies described above. The number of cells per inoculum was varied within the range 2.5 × 10 4 -1.3 × 10 6 . The mice were killed on day 5 (A-07) or day 7 (D-12) after the inoculation. Small vascularized tumours had developed in the inoculation sites at that time. The skin around the inoculation sites was removed and the tumours were located with a dissecting microscope. Angiogenesis was quantified by counting the capillaries in the dermis oriented towards the tumours (Rofstad, 1994) . The number of capillaries was corrected for the background, determined after the injection of 10 µl HBSS. The tumours were dissected free from the skin and weighed after the tumour-oriented capillaries had been scored. The number of capillaries was plotted versus the number of cells per inoculum, and linear regression lines were fitted to the data.
Treatment with anti-VEGF neutralizing antibody
The specific role of VEGF in metastasis and angiogenesis was investigated by assessing metastatic efficiency and angiogenic potential in mice treated with the anti-human VEGF neutralizing monoclonal antibody MAB293 (R&D Systems, Inc., Minneapolis, MN, USA). This antibody is produced from a murine hybridoma elicited from a mouse immunized with purified insect cell line Sf 21-derived recombinant human VEGF. The antibody does not cross-react with human platelet derived growth factor. Two doses of MAB293 of 25 µg in 0.2 ml of phosphate-buffered saline (PBS) were administered to the mice by intraperitoneal (i.p.) injection. The first dose was given 1 h before and the second dose 23 h after tumour cells were inoculated either into the lateral tail vein for formation of lung colonies or i.d. for evocation of angiogenesis and tumour formation.
Western blot analysis of intracellular VEGF
Cells were washed in PBS and boiled in Laemmli sample buffer for 5 min (Laemmli, 1970) . Proteins were separated by electrophoresis in 13% sodium dodecyl sulphate-polyacrylamide gels and blotted to polyvinylidene difluoride transfer membranes (Towbin et al, 1979) . Membranes were incubated with the A-20 anti-VEGF rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) for 60 min. Bound antibody was detected using a biotin-streptavidin alkaline phosphatase staining procedure.
ELISA analysis of VEGF secretion
VEGF concentration in culture medium was measured using a commercially available human VEGF 165 enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Inc., Minneapolis, MN, USA) according to manufacturer's instructions. Medium samples were collected from cell cultures immediately before and after a 24-h hypoxia treatment, centrifuged to remove particulates, and assayed in duplicate. Absorbances were read at 450 nm. Readings at 570 nm were subtracted from the readings at 450 nm to correct for optical imperfections in the plates. Rate of VEGF secretion (R sec ) was calculated as where ∆C is the increase in VEGF concentration during the time interval ∆t (24 h), N i and N f are the initial and final cell numbers and V is the volume of medium. The second factor of this product is based on the assumption that the cell number increased exponentially with time during ∆t, an assumption which was verified to be fulfilled for aerobic control cultures. There was no cell proliferation under hypoxic conditions, i.e. the second factor of the product was ~ 1 for hypoxic cultures. Replicate cultures were used to determine N i . Cell numbers were counted using a haemocytometer. The fraction of Trypan-blue-excluding cells after treatment was > 95% and similar for control and hypoxia-treated cultures.
Statistical analysis
Results are presented as arithmetic mean ± s.e.m. Statistical comparisons of mean values were performed under conditions of normality and equal variance by using the Student's t-test for single comparisons and one-way analysis of variance (ANOVA) and the Student-Newman-Keuls test for multiple comparisons. All P-values were determined from two-sided tests. Probability values of P < 0.05 were considered significant. The statistical analysis was performed using SigmaStat statistical software (Jandel Scientific GmbH, Erkrath, Germany).
RESULTS
Exposure to hypoxia resulted in a transient increase in the metastatic efficiency of the D-12 cells (Figure 1 ). The metastatic efficiency was highest immediately after the reoxygenation. It increased with the duration of the hypoxia treatment and decreased with the reoxygenation time. A hypoxia treatment of 4 h was sufficient to increase the metastatic efficiency significantly. Thus, the metastatic efficiency of cell cultures exposed to hypoxia for 4 h was significantly higher than that of aerobic control cultures, whether the hypoxia-treated cultures were assayed immediately (< 1 h) after (P < 0.01) or 4 h after (P < 0.05) the reoxygenation. The maximum increase in metastatic efficiency was most likely reached after a hypoxia treatment of 16-24 h. Cell cultures exposed to hypoxia for 24 h and assayed immediately after or 4 h after the reoxygenation showed a metastatic efficiency which was higher than that of aerobic control cultures by factors of 3-4 (P < 0.005) and 2-3 (P < 0.01) respectively. A reoxygenation time of 24 h was sufficient to eliminate the hypoxia-induced increase in metastatic efficiency. Thus, the metastatic efficiency of cell cultures exposed to hypoxia for 24 h and assayed 24 h after the reoxygenation was not significantly different from that of aerobic control cultures (P > 0.05). In contrast, exposure to hypoxia did not change the metastatic efficiency of the A-07 cells ( Figure 1) ; cell cultures exposed to hypoxia for 4, 8, 16 or 24 h and assayed immediately after, 4 h after or 24 h after the reoxygenation showed a metastatic efficiency which was not significantly different from that of aerobic control cultures (P > 0.05). The metastasis data presented in Figure 1 were calculated by taking into consideration the PE in vitro of the cell cultures (Table 1) . The PE values of cell cultures treated equally were not significantly different for A-07 and D-12 cells (P > 0.05; Figure 2 ).
The transplantability of the D-12 cells also increased transiently by exposure to hypoxia, independent of the number of cells per inoculum ( Figure 3) . It was highest immediately after the reoxygenation and decreased with the reoxygenation time, similar to the metastatic efficiency. Thus, the transplantability of cell cultures exposed to hypoxia for 24 h was significantly higher than that of aerobic control cultures when the hypoxia-treated cultures were assayed immediately after (P < 0.005) or 4 h after the reoxygenation (P < 0.01). Moreover, the cell cultures assayed immediately after the reoxygenation showed a significantly higher transplantability than the cell cultures assayed 4 h after the reoxygenation (P < 0.01). A reoxygenation time of 24 h was sufficient to eliminate the hypoxia-induced increase in transplantability; cell cultures assayed 24 h after the reoxygenation showed a transplantability which was not significantly different from that of aerobic control cultures (P > 0.05; data not shown). In contrast, exposure to hypoxia did not change the transplantability of the A-07 cells ( Figure 3) ; the transplantability of cell cultures exposed to hypoxia for 24 h and assayed immediately after or 4 h after the reoxygenation was not significantly different from that of aerobic control cultures (P > 0.05). Hypoxia treatment also increased transiently the angiogenic potential of the D-12 cells (Figure 4) . The magnitude of the increase was independent of the number of cells per inoculum. The kinetics were similar to the kinetics of the transient increases in metastatic efficiency and transplantability. Thus, after a hypoxia treatment of 24 h, the angiogenic potential was significantly higher for cell cultures assayed immediately after the reoxygenation than for cell cultures assayed 4 h after the reoxygenation (P < 0.01), which in turn showed a significantly higher angiogenic potential than aerobic control cultures (P < 0.01). The hypoxia-induced increase in angiogenic potential was eliminated 24 h after the reoxygenation; the angiogenic potential of cell cultures assayed 24 h after the reoxygenation did not differ significantly from that of aerobic control cultures (P > 0.05; data not shown). In contrast, (Figure 4) ; cell cultures exposed to hypoxia for 24 h and assayed immediately after or 4 h after the reoxygenation showed an angiogenic potential which was not significantly different from that of aerobic control cultures (P > 0.05). There was a strong correlation between tumour weight and number of tumour-oriented capillaries for each cell line (P < 0.0001; data not shown).
Western blot analysis showed that the concentration of intracellular VEGF protein was similar in A-07 and D-12 cells ( Figure 5 ). Three bands were detected, possibly corresponding to glycosylated VEGF 165 , non-glycosylated VEGF 165 and VEGF 121 . If so, non-glycosylated VEGF 165 and VEGF 121 were up-regulated in cell cultures exposed to hypoxia for about 4 h and 24 h, respectively. In contrast, the rate of VEGF secretion differed between the cell lines ( Figure 6 ). The A-07 cells showed a higher secretion rate than the D-12 cells, both under aerobic (P < 0.005) and hypoxic (P < 0.01) conditions. The secretion rate was higher for hypoxic cultures than for aerobic cultures by factors of approximately 1.5 (A-07; P < 0.05) and 7 (D-12; P < 0.001). The absolute increase in VEGF secretion rate was higher for the A-07 cells than for the D-12 cells (P < 0.05; Figure 6 ). Consequently, the D-12 cells, which showed significant hypoxia-induced increases in metastatic efficiency, transplantability and angiogenic potential, had a lower VEGF secretion rate under aerobic conditions and a lower hypoxia-induced increase in the VEGF secretion rate than the A-07 cells, which did not show significant hypoxia-induced increases in metastatic efficiency, transplantability and angiogenic potential. Treatment of host mice with neutralizing antibody against VEGF resulted in a decrease in the metastatic efficiency of the D-12 cells (Figure 7) . The metastatic efficiency in untreated mice was higher than that in antibody-treated mice by a factor of 2-3 for aerobic control cultures (P < 0.05) and by a factor of 5-6 for cell cultures exposed to hypoxia for 24 h and assayed immediately after the reoxygenation (P < 0.001). Hypoxia-treated cultures showed a higher metastatic efficiency than aerobic control cultures in untreated mice (P < 0.05), consistent with the data in Figure 1 . In contrast, the metastatic efficiency of hypoxia-treated cultures was not significantly different from that of aerobic control cultures in antibody-treated mice (P > 0.05). Also the A-07 cells showed reduced metastatic efficiency in mice treated with neutralizing antibody against VEGF (Figure 7) . The metastatic efficiency in untreated mice was higher than that in antibody-treated mice by a factor of 2-3 for both aerobic control cultures (P < 0.05) and cultures assayed immediately after a hypoxia treatment of 24 h (P < 0.05). Aerobic control cultures and hypoxia-treated cultures showed metastatic efficiencies that were not significantly different, either in untreated mice (P > 0.05) or in antibody-treated mice (P > 0.05).
Treatment of host mice with neutralizing antibody against VEGF also resulted in a decrease in the angiogenic potential of the A-07 and D-12 cells (Figure 8 ). The angiogenic potential of aerobic cell cultures was higher in untreated mice than in antibody-treated mice by a factor of approximately 1.5 for both A-07 (P < 0.001) and D-12 (P < 0.01).
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DISCUSSION
Experimental studies of relationships between tumour metastasis, angiogenesis and concentrations of specific angiogenic factors require the use of adequate tumour models. Two human melanoma lines giving rise to pulmonary metastases in athymic nude mice were used as models in the study reported here. These lines are useful models for studies of molecular mechanisms involved in hypoxia-induced changes in metastatic propensity for several reasons. Thus, both cell lines form distinct, well-defined and hence easily scorable lung colonies following intravenous cell inoculation, and there is a linear relationship between the number of lung colonies and the number of inoculated cells in both lines. Moreover, the difference in metastatic efficiency between the lines is not a result of a difference in intrinsic metastatic propensity, but is rather a result of different host immune reactivities against the lines (Rofstad, 1995) .
The study reported here has shown that the metastatic efficiency of human tumour cells can be enhanced by hypoxia. Thus, D-12 cell cultures exposed to hypoxia in vitro, reoxygenated and inoculated i.v. in athymic nude mice showed increased lung colonization efficiency relative to aerobic control cultures. However, hypoxia does not necessarily increase the metastatic efficiency of the cells of all tumours; the lung colonization efficiency of the A-07 cells was not enhanced by hypoxia treatment in vitro. Young et al (1988) have reported previously that exposure to hypoxia in vitro can increase the lung colonization efficiency of murine tumour cells (KHT-C2-LP1 fibrosarcoma and B16F10-A1 melanoma) and attributed the effect to hypoxia-induced DNAoverreplication and unspecific gene amplification. No overall temporal correlation between the increase in lung colonization efficiency following exposure to hypoxia and hypoxia-induced changes in the m-RNA levels for cathepsin B, cathepsin L, nm23, TIMP-1, osteopontin or VEGF was found for these murine tumour cells (Jang and Hill, 1997) .
The mechanism of the hypoxia-induced increase in metastatic efficiency in the D-12 cells was probably fundamentally different from that in the murine tumour cells studied by Young et al (1988) . Firstly, the kinetics as well as the magnitude of the effect differed significantly between the D-12 and the murine tumour cells. When the murine tumour cells were exposed to hypoxia for 18-24 h, the metastatic efficiency was reduced slightly immediately after the reoxygenation, increased with the reoxygenation time, reached a maximum at about 18 h after the reoxygenation and then decayed with the reoxygenation time. In contrast, the metastatic efficiency of the D-12 cells was highest immediately after the reoxygenation, decreased with the reoxygenation time and was similar to that of aerobic control cultures at about 24 h after the reoxygenation. At maximum, the metastatic efficiency was enhanced by a factor of 6-14 in the murine tumour cells and by a factor of only 3-4 in the D-12 cells. Secondly, in contrast to the murine tumour cells, the D-12 cells did probably not show unspecific gene amplification following exposure to hypoxia, as DNA-overreplication similar to that observed by Young et al (1988) in the studies of the murine KHT-C2-LP1 fibrosarcoma and B16F10-A1 melanoma cells could not be detected when D-12 cells were subjected to flow cytometric analyses.
The D-12 cells increased slightly in volume during prolonged (> 8 h) exposure to hypoxia. Increased cell volume might promote the formation of metastases by facilitating the arrest of tumour cells in the microcirculation. Prolonged hypoxia treatment also resulted in inactivation of a significant fraction of the D-12 cells. Since cell inactivation by hypoxia can be cell cycle-dependent (Spiro et al, 1984) , the cell cycle distribution of the noninactivated D-12 cells might have differed from that of the aerobic control cells. The lung colonization ability of cells can depend on their position in the cell cycle (Suzuki et al, 1977) . However, it is unlikely that the hypoxia-induced increase in metastatic efficiency in the D-12 cells can be attributed to hypoxia-induced alterations in cell volume or cell cycle distribution. The hypoxia-induced alterations in cell volume and PE were similar in the D-12 and the A-07 cells, and the A-07 cells did not show increased metastatic efficiency following exposure to hypoxia. Moreover, the metastatic efficiency of the D-12 cells was enhanced by a factor of 2-3 immediately after a hypoxia treatment of 4-8 h, and a hypoxia treatment of 4-8 h did not cause significant alterations in cell volume or PE.
The hypoxia-induced increase in metastatic efficiency in the D-12 cells was rather a result of a hypoxia-induced increase in angiogenic potential. Thus, the D-12 cells, which showed hypoxia-induced metastasis, evoked increased angiogenesis following exposure to hypoxia, whereas the A-07 cells, which did not show hypoxia-induced metastasis, did not. Moreover, tumour transplantability, which also is angiogenesis-dependent, was enhanced following hypoxia treatment in the D-12 cells but not in the A-07 cells. Finally, the kinetics of the hypoxia-induced increases in metastasis and transplantability were similar to that of the hypoxia-induced increase in angiogenic potential.
VEGF was probably involved in the hypoxia-induced angiogenesis causing the enhanced metastatic efficiency of hypoxia-treated D-12 cells. Thus, non-glycosylated VEGF 165 and VEGF 121 were clearly up-regulated in cell cultures exposed to hypoxia for about 4 h and 24 h respectively. The rate of VEGF secretion in vitro was higher under hypoxic conditions than under aerobic conditions by a factor of approximately 7. Moreover, the metastatic efficiency and the angiogenic potential of the D-12 cells were reduced significantly in mice treated with neutralizing antibody against VEGF. Hypoxia-treated and aerobic control cultures showed similar metastatic efficiencies in antibody-treated mice. However, the present study does of course not exclude the possibility that angiogenic factors other than VEGF also were involved in the hypoxia-induced increases in metastatic efficiency and angiogenic potential in the D-12 cells.
The neovascularization and expansion of micrometastases do not occur until several days after their establishment. Northern blot analyses have shown that hypoxia-induced VEGF up-regulation in vitro decreases with the time after reoxygenation with a half-life of a few hours (Shweiki et al, 1992; Hlatky et al, 1994) , consistent with the observation that a reoxygenation time of 24 h, but not a reoxygenation time of 4 h, was sufficient to eliminate the hypoxiainduced increase in metastatic efficiency in the D-12 cells. Consequently, the later phases of the angiogenic process were probably not influenced significantly by exposing the D-12 cells to hypoxia. It is predominantly more likely that VEGF contributed to the hypoxia-induced increase in the metastatic efficiency of the D-12 cells by potentiating the initial phase of angiogenesis, i.e. by stimulating the expression of endothelial cell proteases and hence the degradation of the basement membrane (Unemori et al, 1992; Mandriota et al, 1995) .
Perhaps more importantly, VEGF may have contributed significantly to the increased metastatic efficiency of hypoxia-treated D-12 cells by a mechanism which is only partly related to the process of angiogenesis. VEGF is known also as vascular permeability factor based on its ability to induce vascular leakage in several organs, including skin and peritoneal wall (Senger et al, 1983; Dvorak, 1986; Nagy et al, 1995) . VEGF increases microvascular permeability through activation of vesicular-vacuolar organelles in endothelial cells (Feng et al, 1996) and through the induction of inter-endothelial cell gaps and endothelial fenestration (Roberts and Palade, 1995) . The vascular permeabilizing effect occurs rapidly, becoming evident within several minutes after VEGF exposure (Dvorak et al, 1979; Senger et al, 1983; Nagy et al, 1995) . VEGF may therefore have increased the metastatic efficiency of hypoxia-treated D-12 cells by facilitating cell extravasation into the lungs. Moreover, increased microvascular permeability is probably also a crucial step in tumour angiogenesis, as Dvorak (1986) has presented evidence that a major function of VEGF in the angiogenic process is the induction of plasma protein leakage, an effect which results in the formation of an extravascular fibrin gel serving as a substrate for endothelial and tumour cell growth. Consequently, the vascular permeabilization effect of VEGF may have contributed to the hypoxia-induced increase in the metastatic efficiency of the D-12 cells not only by assisting cell extravasation, but also by potentiating tumour angiogenesis after the extravasation. Thus, this interpretation of the metastasis data is consistent with the observation that the transplantability of the D-12 cells was increased by exposure to hypoxia.
Also the A-07 cells showed VEGF upregulation under hypoxic conditions in vitro, but these cells, in contrast to the D-12 cells, did not show hypoxia-induced metastasis and angiogenesis. Several observations suggest that the lack of hypoxia-induced metastasis and angiogenesis in the A-07 cells was not due to the VEGF of these cells being inactive in vivo. Thus, the metastatic efficiency and the angiogenic potential of the A-07 cells were reduced significantly in mice treated with neutralizing antibody against VEGF, similar to what was seen for the D-12 cells. Moreover, ten of ten mice have been found to develop ascitic fluid following intraperitoneal (i.p.) inoculation of 1.0 × 10 6 A-07 cells, whereas i.p. inoculation of 1.0 × 10 6 D-12 cells resulted in the development of ascites in only one of ten mice (unpublished data). Similar studies of human ovarian carcinomas in athymic nude mice have shown that the production of ascites is directly associated with the expression of active VEGF (Yoneda et al, 1998) . Finally, the Western blot analyses suggested that the same isoforms of VEGF were expressed by A-07 and D-12 cells, both under aerobic and hypoxic conditions.
The lack of hypoxia-induced metastasis and angiogenesis in the A-07 cells was probably rather a consequence of the high expression of VEGF under aerobic conditions; the aerobic rate of VEGF secretion was higher in the A-07 cells than in the D-12 cells by a factor of approximately 40. It is therefore possible that VEGF was a limiting factor for the development of metastases and the rate of angiogenesis in the D-12 cells but not in the A-07 cells. If so, exposure of the A-07 cells to hypoxia just led to increased secretion of redundant VEGF.
The present study has significant influence on our understanding of the role of VEGF in the angiogenesis of malignant melanoma. If the data presented here are representative for melanomas in man, three important conclusions may be derived. Firstly, melanomas in different patients can differ substantially in VEGF expression. Secondly, VEGF may be a limiting factor for the rate of angiogenesis in low VEGF-expressing melanomas but not in high VEGF-expressing melanomas under normoxic conditions. Thirdly, the VEGF expression in low VEGF-expressing melanomas may be up-regulated by hypoxia to an extent sufficient to increase the rate of angiogenesis. Consequently, the rate of VEGF secretion might be an important determinant of the rate of angiogenesis in malignant melanoma. This suggestion is consistent with the observation that human melanoma xenografts transfected with VEGF can show increased vascular density relative to non-transfected control tumours (Claffey et al, 1996; Pötgens et al, 1996) .
Our understanding of the mechanisms governing the development of metastases in malignant melanoma is also influenced significantly by the present study. Melanomas gradually develop aggressive phenotypic traits with time, including invasive growth and metastatic spread (Herlyn, 1990) , a property they have in common with several histological types of cancer (Foulds, 1975) . This process is termed malignant progression and has been suggested to be a result of genomic instability (Hill, 1990) . Evidence has been presented that tumour hypoxia followed by reoxygenation might increase the genomic instability of tumours and hence promote the formation of metastatic cell phenotypes (Hill, 1990; Brown and Giaccia, 1994; Dachs and Stratford, 1996) . The study reported here suggests an additional mechanism by which acute hypoxia might promote the development of metastases in melanoma. Melanoma cells intravasating from tumour regions subjected to transient stoppages in microregional blood flow might show up-regulated VEGF expression and hence have elevated capacity to extravasate, induce neovascularization and give rise to macroscopic metastatic growth when trapped in the capillary bed of a distant organ such as the lungs. It should be noted that our data suggest that this mechanism of hypoxiainduced metastasis applies only to melanomas showing low VEGF expression under normoxic conditions and that the increased metastatic efficiency induced during hypoxia is a transient phenomenon; the metastatic efficiency might be significantly elevated at least until 4 h after the reoxygenation, but probably not until 24 h after the reoxygenation.
The mechanism of hypoxia-induced metastasis suggested here is consistent with data from clinical studies involving soft tissue sarcoma, cervix carcinoma and carcinoma of the head and neck showing that primary tumours with low oxygen tensions or high lactate concentrations metastasize more frequently than primary tumours with high oxygen tensions or low lactate concentrations (Schwickert et al, 1995; Brizel et al, 1996; Höckel et al, 1996; Walenta et al, 1997; Sundfør et al, 1998) . It is also consistent with observations showing that the probability of metastasis in many tumour types is positively correlated to the vascular density in vascular 'hot spots' of the primary tumour, as vascular 'hot spots' might result from hypoxia-induced angiogenesis mediated by VEGF (Weidner, 1993) .
